Evidence map›Paper›PMID 24690035›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2014

MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis.

Joy X Jiang, Natalie J Török

Open access · greenAbstract readEditorial
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joy X JiangDepartment of Internal Medicine, Division of Gastroenterology, Hepatology UC Davis Medical Center, Sacramento, CA, USA.
Natalie J Török
University of California Davis Medical Center · US

Funding

Galectin-3 in Liver FibrosisK01DK090121 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JIANG, XIAOSONG JOY · 2012 to 2016
$589k
The Role of NOX2 in Liver FibrosisR03DK080715 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TOROK, NATALIE J. · 2008 to 2009
$152k
NIDDK NIH HHS K01 DK090121NIDDK NIH HHS R03 DK080715
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDisease ProgressionHumansMAP Kinase Kinase KinasesMAP Kinase Signaling SystemMiceMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase Kinase Kinase 11Non-alcoholic Fatty Liver DiseaseMAP Kinase Kinase KinasesMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase Kinase Kinase 11

Identifiers

PMID24690035
PMCPMC4392882
OpenAlexW2060528733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.